Similar articles

• Letter: Minocycline activity against tetracycline-resistant Staphylococcus aureus.

  Leigh DA. Leigh DA. Lancet. 1975 Apr 19;1(7912):919. doi: 10.1016/s0140-6736(75)91719-5. Lancet. 1975. PMID: 47564 No abstract available.
• Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use.

  Lewis SA, Altemeier WA. Lewis SA, et al. Chemotherapy. 1976;22(5):319-23. doi: 10.1159/000221939. Chemotherapy. 1976. PMID: 947710
• Letter: In-vitro minocycline activity against tetracycline-resistant staphylococcus aureus.

  Mitchell AA. Mitchell AA. Lancet. 1975 Mar 8;1(7906):576. doi: 10.1016/s0140-6736(75)91595-0. Lancet. 1975. PMID: 47049 No abstract available.
• Tigecyclin--the first glycylcycline to undergo clinical development: an overview of in vitro activity compared to tetracycline.

  Felmingham D. Felmingham D. J Chemother. 2005 Aug;17 Suppl 1:5-11. doi: 10.1179/joc.2005.17.Supplement-1.5. J Chemother. 2005. PMID: 16285353 Review.
• Recent developments in tetracycline antibiotics.

  Sum PE, Sum FW, Projan SJ. Sum PE, et al. Curr Pharm Des. 1998 Apr;4(2):119-32. Curr Pharm Des. 1998. PMID: 10197036 Review.